Publicaciones en las que colabora con AMADO ANDRÉS BELMONTE (13)

2022

  1. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study

    Clinical transplantation, Vol. 36, Núm. 3, pp. e14550

  2. The Immunobiogram, a novel in vitro diagnostic test to measure the pharmacodynamic response to immunosuppressive therapy in kidney transplant patients

    Transplant Immunology, Vol. 75

2021

  1. Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a spanish multicenter cohort

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 5

  2. Pre-emptive rituximab in focal and segmental glomerulosclerosis patients at risk of recurrence after kidney transplantation

    Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 139-148

2018

  1. Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

    Clinical Microbiology and Infection, Vol. 24, Núm. 2, pp. 192-198

2016

  1. Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 11, pp. 3220-3234

  2. Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study

    American Journal of Transplantation, Vol. 16, Núm. 7, pp. 2148-2157

2014

  1. Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study

    Clinical Immunology, Vol. 154, Núm. 2, pp. 141-154

  2. Spanish consensus document for acceptance and rejection of kidneys from expanded criteria donors

    Clinical Transplantation, Vol. 28, Núm. 10, pp. 1155-1166

2013

  1. The impact of darbepoietin alfa in early post-transplant anaemia management: Retrospective exploratory study

    Nefrologia, Vol. 33, Núm. 1, pp. 107-115

2009

  1. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

    Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32

2006

  1. Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain

    Journal of the American Society of Nephrology

2002

  1. Risk factors of ischemic heart disease after renal transplantation

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 394-395